Limin Xia

6.4k total citations · 3 hit papers
142 papers, 4.1k citations indexed

About

Limin Xia is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Limin Xia has authored 142 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 34 papers in Cancer Research and 33 papers in Oncology. Recurrent topics in Limin Xia's work include RNA modifications and cancer (19 papers), Epigenetics and DNA Methylation (18 papers) and Cancer-related molecular mechanisms research (13 papers). Limin Xia is often cited by papers focused on RNA modifications and cancer (19 papers), Epigenetics and DNA Methylation (18 papers) and Cancer-related molecular mechanisms research (13 papers). Limin Xia collaborates with scholars based in China, United States and South Korea. Limin Xia's co-authors include Wenjie Huang, Kaichun Wu, Dean Tian, Daiming Fan, Yongzhan Nie, Tongyue Zhang, Yijun Wang, Danfei Liu, Zhangqian Chen and Mengyu Sun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Cell and The Journal of Immunology.

In The Last Decade

Limin Xia

134 papers receiving 4.1k citations

Hit Papers

FGF19/FGFR4-mediated elev... 2023 2026 2024 2023 2024 2025 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
    2023 112 citations Meng Xie, Zhuoying Lin et al. Journal of Hepatology profile →
  2. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
    2024 72 citations Junli Lu, Xiaoping Chen et al. profile →
  3. Cancer stem cells and niches: challenges in immunotherapy resistance
    2025 32 citations Yonglong Pan, Chaoyi Yuan et al. Molecular Cancer profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Limin Xia 2.8k 1.4k 1.0k 594 512 142 4.1k
Oliver Stoeltzing 3.0k 1.1× 1.4k 1.0× 1.6k 1.5× 383 0.6× 538 1.1× 73 4.6k
Akiteru Goto 1.9k 0.7× 1.0k 0.8× 973 1.0× 400 0.7× 684 1.3× 134 3.7k
Julia I-Ju Leu 2.6k 0.9× 867 0.6× 1.6k 1.6× 292 0.5× 497 1.0× 36 3.8k
Goutham Narla 4.2k 1.5× 994 0.7× 658 0.7× 385 0.6× 337 0.7× 108 5.3k
Atul Bedi 3.2k 1.1× 2.0k 1.5× 1.6k 1.6× 639 1.1× 418 0.8× 29 4.8k
Amaia Lujambio 4.2k 1.5× 2.8k 2.0× 1.2k 1.2× 764 1.3× 631 1.2× 54 6.1k
Yin Sun 3.1k 1.1× 1.6k 1.2× 758 0.8× 296 0.5× 724 1.4× 116 4.2k
John D. Hooper 1.9k 0.7× 1.1k 0.8× 1.1k 1.1× 406 0.7× 468 0.9× 120 4.1k
Valentina Vaira 2.3k 0.8× 1.2k 0.9× 834 0.8× 282 0.5× 641 1.3× 115 3.9k
Wen Yang 2.0k 0.7× 1.2k 0.9× 887 0.9× 342 0.6× 193 0.4× 42 3.2k

Countries citing papers authored by Limin Xia

Since Specialization
Citations

This map shows the geographic impact of Limin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limin Xia more than expected).

Fields of papers citing papers by Limin Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limin Xia. The network helps show where Limin Xia may publish in the future.

Co-authorship network of co-authors of Limin Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Limin Xia. A scholar is included among the top collaborators of Limin Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limin Xia. Limin Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiaqian, et al.. (2025). The important role of myeloid-derived suppressor cells: From hepatitis to liver cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(3). 189329–189329. 1 indexed citations
2.
3.
Pan, Yonglong, Chaoyi Yuan, Chaoyang Sun, et al.. (2025). Cancer stem cells and niches: challenges in immunotherapy resistance. Molecular Cancer. 24(1). 52–52. 32 indexed citations breakdown →
4.
Yu, Chengpeng, Hanhua Dong, Wei Yan, et al.. (2025). The Hippo-YAP signaling pathway promotes hepatocellular carcinoma progression by inducing FHL3 expression. Cell Death and Disease. 16(1). 789–789. 1 indexed citations
5.
Wang, Yi, et al.. (2024). Field exposure experiments on the influence of low air pressure environment on the air-void structure of air-entrained concrete and its deterioration mechanism. Construction and Building Materials. 453. 139067–139067. 1 indexed citations
6.
7.
Wang, Shuai, Lijun Meng, Huan Chen, et al.. (2024). Hepatocellular carcinoma-specific epigenetic checkpoints bidirectionally regulate the antitumor immunity of CD4 + T cells. Cellular and Molecular Immunology. 21(11). 1296–1308. 5 indexed citations
8.
Xie, Meng, Zhuoying Lin, Xiaoyu Ji, et al.. (2023). FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. Journal of Hepatology. 79(1). 109–125. 112 indexed citations breakdown →
9.
10.
Sun, Mengyu, Weibo Feng, Jie Chen, et al.. (2023). An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma. Frontiers in Genetics. 14. 1056000–1056000. 8 indexed citations
11.
Feng, Weibo, Jie Chen, Wenjie Huang, et al.. (2023). HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2. Theranostics. 13(12). 4042–4058. 21 indexed citations
12.
Wang, Yi‐Jun, Mengyu Sun, Tongyue Zhang, et al.. (2022). Role of chemokines in the hepatocellular carcinoma microenvironment and their translational value in immunotherapy*. Oncology and Translational Medicine. 8(1). 1–17. 1 indexed citations
13.
Feng, Weibo, et al.. (2022). [T cell factor 3 (TCF3) is overexpressed in hepatocellular carcinoma and promotes their invasion and metastasis].. PubMed. 38(1). 66–73.
14.
Ji, Qiang, Yulin Wang, Ye Yang, et al.. (2021). Hypertrophic cardiomyopathy with latent obstruction: Clinical characteristics and surgical results. Journal of Cardiology. 79(1). 42–49. 5 indexed citations
15.
16.
17.
Ji, Qiang, Yun Zhao, Yulin Wang, et al.. (2019). Elderly Patients with Moderate Chronic Ischemic Mitral Regurgitation: Coronary Artery Bypass Grafting Alone or Concomitant Mitral Annuloplasty?. Cardiology Research and Practice. 2019. 1–8.
18.
Huang, Wenjie, Zhangqian Chen, Xin Shang, et al.. (2015). Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up‐regulating Twist1 and FGFBP1. Hepatology. 61(6). 1920–1933. 97 indexed citations
19.
Yang, Zhaohua, Can Wang, Shouguo Yang, et al.. (2014). Endothelial progenitor cells induce transplant arteriosclerosis via VEGFR-1/2 activity. Atherosclerosis. 238(1). 26–32. 6 indexed citations
20.
Xia, Limin, Wenjie Huang, Jianguo Wu, et al.. (2009). HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-κB. Virology. 385(2). 335–342. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Stoeltzing Breakdown of academic impact, for papers by Akiteru Goto Breakdown of academic impact, for papers by Julia I-Ju Leu Breakdown of academic impact, for papers by Goutham Narla Breakdown of academic impact, for papers by Atul Bedi Breakdown of academic impact, for papers by Amaia Lujambio Breakdown of academic impact, for papers by Yin Sun Breakdown of academic impact, for papers by John D. Hooper Breakdown of academic impact, for papers by Valentina Vaira Breakdown of academic impact, for papers by Wen Yang
Rankless by CCL
2026